Rettenmier Suzanne
Director/Board Member at ALSP ORCHID ACQUISITION CORPORATION I
Network origin in Rettenmier Suzanne first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.
39
| Holding Company | Investment Managers | 39 |
| Private Company | Financial Conglomerates | 11 | |
Lydian Neurosciences Corp.
 Lydian Neurosciences Corp. SemiconductorsElectronic Technology Lydian Neurosciences Corp. develops molecules for treatment. Le. The CEO of the American company is Thong Q.
1
| Holding Company | Semiconductors | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rettenmier Suzanne via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Founder Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree | |
Lodo Therapeutics Corp.
 Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Founder | |
Proniras Corp.
 Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Founder | |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Chief Executive Officer | |
Acylin Therapeutics, Inc.
 Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member Director/Board Member | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Founder Director/Board Member | |
Magnolia Neurosciences Corp.
 Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Biotechnology | Chief Executive Officer Director/Board Member Private Equity Investor | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Founder Director/Board Member | |
| Texas A&M University | College/University | Undergraduate Degree Doctorate Degree | |
W Fund Management LLC
 W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | Investment Managers | Investment Committee Member Investment Committee Member | |
ApoGen Biotechnologies, Inc.
 ApoGen Biotechnologies, Inc. BiotechnologyHealth Technology ApoGen Biotechnologies, Inc. operates as a biotechnology firm, which focuses on the development of therapeutics targeting drivers of cancer genomic mutation. The company was founded by John T. Santini, Jr., Reuben S. Harris, and Daniel A. Harki in 2014 and is headquartered in Seattle, WA. | Biotechnology | Chief Executive Officer Founder | |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Alexandria Agtech/Climate Innovation Acquisition Corp.
 Alexandria Agtech/Climate Innovation Acquisition Corp. Financial ConglomeratesFinance Alexandria Agtech/Climate Innovation Acquisition Corp. operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 18, 2021 and is headquartered in Pasadena, CA. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
WRF Capital
 WRF Capital Investment ManagersFinance WRF Capital (WRF Capital) is a venture capital firm founded in 1994 by Ronald Howell. The firm is headquartered in Seattle, Washington. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Hc Bioscience, Inc.
 Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology hC Bioscience, Inc. is a biotech company based in Cambridge, MA and has subsidiaries in the United States. A single trna therapy has the potential to treat many diseases, regardless of the gene or location of the mutation. hC Bioscience is dedicated to improving the lives of patients by developing first-in-class trna-based therapeutics that target protein dysfunction. The company's innovative approach to precision protein editing has the potential to treat genetically defined conditions that account for 10-15% of all human diseases. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). The company was founded in 2021 by Leslie J. Williams, who has been the CEO since then. | Pharmaceuticals: Major | Chairman Founder | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
Trishula Therapeutics, Inc.
 Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| The Rockefeller University | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Chief Tech/Sci/R&D Officer Doctorate Degree | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of British Columbia | College/University | Doctorate Degree Doctorate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | General Counsel Corporate Officer/Principal | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Cogenics Icoria, Inc.
 Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chief Executive Officer Private Equity Investor | |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Pharmaceuticals: Other | Corporate Officer/Principal President | |
ISB Accelerator Corp.
 ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services ISB Accelerator Corp. is involved in the study of biological systems to help identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. The company is located in Seattle, WA. | Miscellaneous Commercial Services | President Chief Executive Officer | |
| OMEROS CORPORATION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Iowa | College/University | Doctorate Degree Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 48 |
| Canada | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 5 |
Operational
| Director/Board Member | 267 |
| Corporate Officer/Principal | 110 |
| Founder | 56 |
| Chief Executive Officer | 47 |
| President | 46 |
Most connected contacts
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Joel Marcus | 57 |
| Leroy Hood | 34 |
| Thong Le | 30 |
| Bruce Carter | 25 |
| Wendy Johnson | 23 |
| Sundar Kodiyalam | 21 |
| Jan Lundberg | 21 |
| Leslie Williams | 19 |
| Anil Singhal | 18 |
| Eugene Yeo | 17 |
| Lee Babiss | 17 |
| Court Turner | 17 |
| Andras Forgacs | 16 |
| Ian Howes | 14 |
- Stock Market
- Insiders
- Rettenmier Suzanne
- Company connections
